Loading...

One-Minute Summary

> Key Conclusions:

> - Dry needling: economical, entry-level option; effective for short-term myofascial pain but more prone to relapse.

> - Dextrose prolotherapy: best for "chronic degeneration at musculotendinous junctions"; gentle collagen stimulation.

> - PRP: a 2022 RCT showed superior long-term outcomes vs dry needling for severe chronic myofascial pain, especially in patient satisfaction.

> - Clinical decision logic: depends on pain duration, severity, and presence of structural degeneration.

> - Common foundation: all three therapies outperform "pain medications without addressing the source."

What Is Myofascial Pain? Why Is It So Hard to Treat?

Myofascial pain syndrome (MPS) is one of the most common causes of chronic pain. Its hallmark is the "trigger point" — a tense knot within muscle that, when pressed:

• Hurts

• Refers pain to a distant area

• Elicits a local twitch response in specific muscles

Why is it hard to treat?

Multifactorial pathogenesis: ischemia, inflammation, neural sensitization, and postural imbalance all contribute

Chronification: untreated MPS develops "central sensitization," changing the pain system itself

Single-modality therapies are often insufficient: medications, rehabilitation, and massage each have limits

> Key insight: Chronic myofascial pain treatment requires precision intervention at the trigger point — this is the value of injection therapies.

Three Mainstream Injection Therapies

Therapy A: Dry Needling

Mechanism:

A fine needle (no injectate) penetrates the trigger point, eliciting a local twitch response that disrupts abnormal electrophysiological loops.

Strengths:

• Economical (no medication cost)

• Rapid effect on short-term myofascial pain

• Very few side effects

• Short procedure time

Limitations:

• Effects typically diminish after 1–3 months

• Limited efficacy for severe degeneration or structural problems

• "Treatment soreness" notable on day of and day after

Best Indications:

• Short-to-mid-term myofascial tension

• Upper back, neck-shoulder, low back trigger points

• Patients sensitive to medication side effects

• Budget considerations

Therapy B: Dextrose Prolotherapy

Mechanism:

Inject 12.5–25% dextrose solution at the trigger point and surrounding tendon/ligament insertions. Dextrose causes a mild inflammatory response, stimulating collagen synthesis and promoting repair of chronically degenerated tissue.

Strengths:

• Best for "chronic degeneration at musculotendinous junctions"

• Unique advantage for ligamentous laxity and chronic fascial pain

• Moderate cost

• Few side effects

Limitations:

• Slower onset (typically 4–8 weeks)

• More painful injection

• For pure trigger points (no structural degeneration), efficacy is not necessarily superior to dry needling

Best Indications:

• Chronic low back pain with ligamentous laxity

• Chronic neck pain with facet joint dysfunction

• Chronic post-injury musculotendinous junction pain

• Recurrent injury sites

Therapy C: PRP Injection

Mechanism:

PRP delivers high-concentration growth factors (PDGF, TGF-β, VEGF, IGF-1):

• Stimulates stem cell activation

• Promotes angiogenesis

• Suppresses chronic inflammation

• Accelerates tissue repair

Evidence (2022 RCT):

> Comparing PRP vs dry needling for masseter trigger points: PRP group showed significantly superior pain improvement and patient satisfaction.

Strengths:

• Best long-term outcomes for severe chronic pain

• Autologous-blood source, no foreign-body rejection

• Simultaneously addresses inflammation and promotes repair

• Some studies show effects lasting 6–12 months

Limitations:

• Higher cost

• Slower onset (peak 4–8 weeks)

• Requires autologous blood draw

• Brief swelling at injection site

Best Indications:

• Severe chronic myofascial pain (>6 months)

• Patients with diminishing response to dry needling or medications

• Athletes and high-demand activities

• Budget allowing pursuit of best long-term outcomes

Comprehensive Comparison

Clinical Decision Framework: Which to Choose?

Decision Tree

Step 1: How long has the pain persisted?

• 6 months: consider dextrose prolotherapy or PRP directly

Step 2: Structural degeneration on imaging?

• No structural degeneration, pure myofascial tension: dry needling or PRP

• Structural degeneration (chronic tendon/ligament injury): dextrose prolotherapy or PRP

Step 3: Budget and time

• Budget-limited: start with dry needling

• Moderate budget: dextrose prolotherapy

• Budget allows + best long-term outcome priority: PRP

Stepwise Strategy (Most Common)

Many physicians use "try simple first, upgrade if insufficient":

Month 1: dry needling × 4 sessions

Evaluate: ≥50% improvement → continue maintenance

Key insight: Chronic multifocal myofascial pain often requires a "whole-body treatment strategy" — not just one injection point. Combine with posture correction, strength training, and lifestyle adjustment for the long-term solution.

Common Success Factors

Regardless of injection choice, the following affect success:

Physician Side

Precise trigger point localization: palpation, ultrasound, EMG verification

Correct injection technique: angle, depth, retrograde release

Reasonable protocol design: number, intervals, evaluation points

Integrated treatment plan: injection is one component

Patient Side

Adherence to rehab exercises: moderate activity within 24 hours post-injection

Posture and lifestyle adjustment: remove pain-causing factors

Patience for onset: especially PRP and prolotherapy

Track pain scores: helps physician adjust the plan

Adequate sleep and nutrition: foundation for tissue repair

When to Consider Other Approaches?

Injection therapy is not a panacea. Consider alternative paths if:

• Pain dominated by radiculopathy (e.g., disc herniation compressing nerve) → nerve decompression-related treatment

• Severe postural etiology (scoliosis, pelvic misalignment) → posture therapist required

• High psychological component (depression, chronic stress) → psychological therapy integration

• Pain is inflammatory disease (rheumatoid, ankylosing spondylitis) → rheumatology

Conclusion: "No Best Therapy, Only the Best Fit"

Every chronic pain patient differs in pain nature, cause, and severity. The three injection therapies each have ideal contexts:

• Dry needling: rapid, economical, entry-level

• Dextrose prolotherapy: chronic degeneration, structural laxity

• PRP: severe chronic, long-term outcome priority

Correct selection requires professional evaluation of your specific situation. See our muscle fascia pain regenerative service or book a consultation.

Medical References

Comparative Efficacy of PRP and Dry Needling for Trigger Points in Masseter Muscle: RCT. PubMed PMID: 36445907. 2022.

Dry Needling Versus Trigger Point Injection for Neck Pain: Systematic Review and Meta-Analysis. PubMed PMID: 34114639.

Comparison of dry needling and trigger point injections in TMJ myofascial pain. PMC6797918.

Trigger Point Injection: Background, Indications, Contraindications. Medscape.

Comparison of lidocaine, botulinum toxin, and dry needling to trigger points. Rheumatology International.

Editorial review: Reviewed by Dr. Da-Ru Liu. Last reviewed 2026-04-27.